Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Completes Acquisition of Lark

NEW YORK , April 2 (GenomeWeb News) - Genaissance Pharmaceuticals and Lark Technologies announced yesterday that the planned acquisition of Lark by Genaissance has been completed.


The deal closed after stockholders from both companies approved the plan. As part of the terms of agreement, each outstanding share of Lark's common stock will be exc han ged for 1.81 shares of Genaissance stock.


Genaissance announced its plan in December to acquire Lark for $19.9 million.


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.